Related Experiment Video
Updated: Dec 16, 2025

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report
Bo Hoon Lee1, Phillip Mongiovi2, Thierry Levade3
1Division of Child Neurology, Department of Neurology, University of Rochester, Rochester, New York, USA.
Insights
Genetic variations in the ASAH1 gene cause Farber disease (FD) and spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME). This study details a boy with novel ASAH1 variants exhibiting features of both FD and SMA.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Genetic variations in the ASAH1 gene are linked to a spectrum of rare disorders.
- These include Farber disease (FD), characterized by inflammatory nodules and joint issues, and spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME), involving motor neuron degeneration, epilepsy, and hearing loss.
Observation:
- A 4-year-old boy presented with a complex phenotype exhibiting characteristics of both Farber disease and spinal muscular atrophy.
- Clinical manifestations included features suggestive of both conditions, necessitating a detailed genetic investigation.
Findings:
- Whole-exome sequencing identified two novel, heterozygous variants in the ASAH1 gene in the patient.
- These previously unreported variants provide a genetic explanation for the patient's combined FD and SMA phenotype.
Implications:
- This case expands the known genotypic and phenotypic spectrum associated with ASAH1 mutations.
- Understanding these novel variants contributes to improved diagnostics and potential therapeutic strategies for patients with ASAH1-related disorders.
- Further research into ASAH1 function is warranted to elucidate the mechanisms underlying this diverse range of clinical presentations.
Abstract:
Genetic variations in the ASAH1 gene are associated with a spectrum of disorders ranging from Farber disease (FD) to spinal muscular atrophy with or without progressive myoclonic epilepsy (SMA-PME). FD presents most commonly in infants with subcutaneous joint nodules, progressive arthritis and granulomas of the larynx and epiglottis leading to a hoarse cry. SMA-PME is characterized by childhood onset progressive weakness due to motor neuron disease followed by progressive epilepsy, tremor, and sensorineural hearing loss. We present a case of a 4-year-old boy with phenotypic features of both FD and SMA who was found to have two previously unreported heterozygous variants in the ASAH1 gene.
More Related Videos
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
12:35Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Lysosomal Hydrolases
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Animal Mitochondrial Genetics